Balmonds Overview
- Founded
-
2007
- Status
-
Public
- Employees
-
10
- Investments
-
1
Balmonds General Information
Description
Developer of skincare products intended to offer products for sensitive skin. The company's products are suitable for dry skin, eczema, psoriasis, dermatitis, and allergy-prone skin and also are a non-steroidal moisturizer that is both prescribed and alternative, enabling users to avail the products at a reasonable rate.
Contact Information
Website
www.balmonds.co.uk
Formerly Known As
Purepotions
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Personal Products
Other Industries
Internet Retail
Primary Office
- PO Box 230
- Brighton BN2 9TX
- England, United Kingdom
+44 01273 000000
Balmonds Financials Summary
|
In Thousands, USD |
TTM 31-Mar-2017 | FY 2017 31-Mar-2017 | FY 2016 31-Mar-2016 | FY 2015 31-Mar-2015 |
|---|---|---|---|---|
| Total Assets | 375 | 375 | 284 | 278 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Balmonds Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Balmonds Executive Team (5)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Weze McIntosh | Managing Director | ||
| Natalie Balmond | Co-Owner & Director | ||
| Andrew Gerrie | Co-Owner & Co-Founder | ||
| Alison Hawksley | Co-Owner |
Balmonds Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Balmonds Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0000000000 00 | 23-May-2022 | 0000000000 | Special Purpose Acquisition Company (SPAC) |